MCK vs KMDA vs QNME Stock Comparison

Mckesson, Kamada and Quanome Technologies Prices as of Oct 29, 2026 Peers: Industry group
MCK Mckesson Corp
$981.33 +13.5% 1M +21.5% 1Y
Market cap
$114.41B
P/E
25.4x
Revenue (TTM)
$410.98B
Div. yield
0.35%
Drug Distribution Healthcare
5 wins
KMDA Kamada Ltd
$7.95 -8.5% 1M +14.9% 1Y
Market cap
$458.60M
P/E
20.7x
Revenue (TTM)
$191.85M
Div. yield
5.28%
Biotechnology Healthcare
6 wins

Head to Head

12 decided of 12

Kamada leads on 6 of the 12 questions below (Kamada 6, Mckesson 5, Quanome Technologies 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMCKKMDAQNMELeader
Larger companyMarket capitalisation $114.41B $458.60M $10.54M MCK
Cheaper on earningsLower P/E, profitable companies only 25.4x 20.7x -1.1x KMDA
Cheaper on forward earningsLower price / next fiscal year consensus EPS 20.8x 15.9x — KMDA
Faster revenue growthRevenue growth, trailing twelve months +8.8% +13.2% +48.5% QNME
More profitableNet margin, trailing twelve months 1.1% 11.5% -62.5% KMDA
Better return on capitalReturn on invested capital 107.9% 10.2% -104.8% MCK
Less leveragedLower net debt / EBITDA 0.6x -1.5x 0.0x KMDA
Higher dividend yieldTrailing dividend yield 0.35% 5.28% — KMDA
Better 1-year returnPrice return, last 12 months +21.5% +14.9% -67.2% MCK
Better 5-year returnAnnualised price return, 5 years +36.4%/yr +6.8%/yr — MCK
Less volatileAnnualised volatility, 1 year 30.8% 34.7% 167.7% MCK
Higher overall scoreMean of the five percentile scores vs peers 59/100 84/100 20/100 KMDA

Percentile Scorecard

MCKKMDAQNME

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMCKKMDAQNME
Valuation 54 #12 of 25 97 #20 of 624 7 #126 of 136
Growth 65 #9 of 24 71 #178 of 601 28 #88 of 121
Profitability 70 #8 of 24 87 #70 of 541 6 #105 of 112
Financial Health 48 #14 of 26 74 #168 of 647 59 #58 of 140
Shareholder Returns 60 #7 of 16 90 #38 of 359 0 #80 of 80
Overall 59 84 20
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • KMDA ranked among 671 companies in Pharmaceuticals and Biotechnology
  • QNME ranked among 150 companies in Transportation

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMCKKMDAQNMESPY
1 month +13.5%-8.5%-30.5% +0.7%
3 months +13.3%+12.0%+57.7% +3.7%
6 months +20.4%-2.3%-31.7% +7.1%
Year to date +19.6%+12.6%-53.9% +12.8%
1 year +21.5%+14.9%-67.2% +11.9%
3 years +118.3%+82.3%— +85.2%
3 years, per year +29.8%+22.2%— +22.8%
5 years +372.1%+39.2%— +67.6%
5 years, per year +36.4%+6.8%— +10.9%
10 years +690.7%+33.6%— +262.0%
10 years, per year +23.0%+2.9%— +13.7%

Risk

MeasureMCKKMDAQNMESPY
Volatility, 1Y 30.8%34.7%167.7% 12.7%
Downside volatility, 1Y 27.4%33.2%131.5% 12.6%
Beta vs S&P 500, 1Y -0.281.011.79 1.00
Return / volatility, 1Y 0.700.43-0.40 0.94
Max drawdown, 5Y -27.2%-44.4%-93.6% -25.4%
From 52-week high -4.7%-14.6%-67.7% -1.2%
52-week high $1,030.18$9.31$1.27 $779.14
52-week low $725.17$6.62$0.26 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMCKKMDAQNME
P/E now vs peer median 25.4xmedian 24.3x 20.7xmedian 17.8x -1.1xmedian 16.5x
P/S now vs peer median 0.3xmedian 0.3x 2.4xmedian 9.1x 0.7xmedian 0.9x
EV/EBITDA now vs peer median 16.4xmedian 12.9x 9.1xmedian 15.0x -0.9xmedian 8.8x
P/FCF now vs peer median 17.8xmedian 16.4x 17.4xmedian 21.7x -3.3xmedian 11.9x
P/B now vs peer median -27.0xmedian 2.5x 1.7xmedian 2.2x 1.5xmedian 1.2x
PEG now vs peer median 2.12median 1.36 0.29median 0.35 —median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMCKKMDAQNME
Revenue $410.98B $191.85M $15.18M
Gross profit $14.96B $78.31M $4.54M
Operating income $6.50B $27.83M -$11.13M
Net income $5.30B $22.25M -$9.48M
Free cash flow $6.42B $26.32M -$3.20M
R&D – $9.91M –
EPS (diluted) $38.52 $0.38 $-0.37
Cash & equivalents $5.16B $29.47M $670.28K
Total debt $9.73B $74.86M $5.60M
Shares (diluted) 119.20M 58.35M 25.72M
Enterprise value $100.87B $167.66M $2.39M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMCKKMDAQNME
P/E 25.4x 20.7x -1.1x
P/FCF 17.8x 17.4x -3.3x
P/Operating cash flow 16.7x 12.8x -3.3x
P/S 0.3x 2.4x 0.7x
P/B -27.0x 1.7x 1.5x
P/Tangible book -13.9x 1.7x 1.6x
EV/EBITDA 16.4x 9.1x -0.9x
EV/EBIT 18.3x 14.2x -0.9x
EV/Revenue 0.3x 2.1x 0.7x
EV/FCF 18.5x 15.0x -3.2x
EV/Operating cash flow 17.4x 11.0x -3.2x
PEG (3Y EPS CAGR) 2.12 0.29 –

Growth

14 metrics
MetricMCKKMDAQNME
Revenue growth (1Y) 8.8% 13.2% 48.5%
Revenue CAGR (3Y) 13.1% 9.6% –
Gross profit growth (1Y) 11.2% 5.9% 134.7%
Gross profit CAGR (3Y) 6.6% 12.9% –
Operating income growth (1Y) 46.6% 10.3% -204.4%
Operating income CAGR (3Y) 13.5% 43.1% –
Net income growth (1Y) 58.1% 17.0% -80.8%
Net income CAGR (3Y) 10.7% 258.5% –
EPS growth (1Y) 52.8% 14.5% 46.4%
EPS CAGR (3Y) 12.0% 70.4% –
Operating cash flow growth (1Y) 4.7% -10.9% -310.9%
Operating cash flow CAGR (3Y) 10.7% 5.6% –
Free cash flow growth (1Y) 6.8% -16.7% -276.5%
Free cash flow CAGR (3Y) 11.3% 1.0% –

Profitability

14 metrics
MetricMCKKMDAQNME
Gross margin 3.6% 40.8% 29.9%
EBITDA margin 1.8% 22.5% -71.3%
Operating margin 1.6% 14.5% -73.3%
Pretax margin 1.6% 13.9% -72.9%
Net margin 1.1% 11.5% -62.5%
FCF margin 1.6% 13.7% -21.1%
Operating cash flow margin 1.7% 18.6% -21.1%
Return on equity – 8.4% -92.0%
Return on assets 6.2% 5.8% -64.4%
Return on invested capital 107.9% 10.2% -104.8%
Return on capital employed 43.4% 8.3% -108.8%
Asset turnover 4.8x 0.5x 1.0x
Cash conversion (OCF / net income) 1.3x 1.6x 0.3x
Stock comp / revenue – 1.1% 21.4%

Financial Health

11 metrics
MetricMCKKMDAQNME
Debt / assets 11.0% 1.6% 2.7%
Debt / equity -2.3x 0.0x 0.0x
Net debt / EBITDA 0.6x -1.5x 0.0x
Debt / FCF 1.5x 0.2x -0.1x
Liabilities / assets 104.8% 29.6% 39.9%
Equity / assets -4.8% 70.4% 60.1%
Interest coverage 23.6x 93.7x -27.4x
Current ratio 0.9x 4.1x 2.5x
Quick ratio 0.5x 2.3x 3.6x
Cash ratio 0.1x 1.4x 0.1x
Altman Z-score 5.90 3.57 -1.59

Shareholder Returns

7 metrics
MetricMCKKMDAQNME
Dividend yield 0.3% 5.3% –
Net buyback yield 5.8% 0.0% -78.1%
Shareholder yield 6.1% 5.3% -78.1%
Payout ratio (earnings) 7.4% 129.6% –
Payout ratio (FCF) 6.1% 109.6% –
Dividend growth (1Y) 11.3% – –
Dividend CAGR (3Y) 10.0% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMCKKMDAQNME
Forward P/E 20.8xFY2026 15.9xFY2026 –
EPS, next fiscal year $47.15FY2026 $0.50FY2026 –
EPS growth, next FY +20.6%FY2026 +38.9%FY2026 –
EPS growth, the year after +11.0% +24.0% –
Revenue, next fiscal year $444.47BFY2026 $209.90MFY2026 –
Revenue growth, next FY +10.2%FY2026 +16.3%FY2026 –
Revenue growth, the year after +1.5% +13.6% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMCKKMDAQNME
Held by institutions 89.1% 8.6% –
Institutions holding 2,011 51 –
Change in shares held, QoQ -0.7% -3.1% –
Institutions buying 883 25 –
Institutions selling 791 18 –
Buyers to sellers 1.12 1.39 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MCKKMDAQNME
MCK 1.00 -0.01 -0.06
KMDA -0.01 1.00 0.05
QNME -0.06 0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MCK, KMDA and QNME?

Mckesson (MCK) is the largest by market capitalisation: Mckesson (MCK) $114.41B, Kamada (KMDA) $458.60M, Quanome Technologies (QNME) $10.54M.

Which stock is cheaper, MCK, KMDA and QNME?

Kamada (KMDA) trades on the lowest price-to-earnings ratio (Mckesson (MCK) 25.4x, Kamada (KMDA) 20.7x, Quanome Technologies (QNME) -1.1x). On next year's consensus earnings, Kamada (KMDA) is cheapest (Mckesson (MCK) 20.8x, Kamada (KMDA) 15.9x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Quanome Technologies (QNME) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.8%, Kamada (KMDA) +13.2%, Quanome Technologies (QNME) +48.5%.

Which company is more profitable?

Kamada (KMDA) has the highest net margin (Mckesson (MCK) 1.1%, Kamada (KMDA) 11.5%, Quanome Technologies (QNME) -62.5%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 107.9%, Kamada (KMDA) 10.2%, Quanome Technologies (QNME) -104.8%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: Mckesson (MCK) +21.5%, Kamada (KMDA) +14.9%, Quanome Technologies (QNME) -67.2%. Over five years, Mckesson (MCK) compounded fastest (Mckesson (MCK) +36.4%/yr, Kamada (KMDA) +6.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Kamada (KMDA) has the highest dividend yield: Mckesson (MCK) 0.35%, Kamada (KMDA) 5.28%. Quanome Technologies (QNME) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (Mckesson (MCK) 30.8%, Kamada (KMDA) 34.7%, Quanome Technologies (QNME) 167.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MCK, KMDA and QNME?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Kamada (KMDA) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.